Successful Rituximab Therapy for Hemolytic Anemia Associated with Relapsed Splenic Marginal Zone Lymphoma with Leukemic Phase

2003 ◽  
Vol 44 (12) ◽  
pp. 2165-2166 ◽  
Author(s):  
Semra Paydas ◽  
Sinan Yavuz ◽  
Umut Disel ◽  
Berksoy Sahin ◽  
Melek Ergin
Keyword(s):  
Hemolytic Anemia ◽  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Splenic Marginal Zone Lymphoma ◽  
Leukemic Phase

Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma

2009 ◽  
Vol 89 (1) ◽  
pp. 113-114 ◽  
Author(s):  
Claudio Fozza ◽  
Antonio Galleu ◽  
Maria Grazia Careddu ◽  
Domenica Barbara Giannico ◽  
Silvana Bonfigli ◽  
...  
Keyword(s):  
Hemolytic Anemia ◽  
Autoimmune Hemolytic Anemia ◽  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Splenic Marginal Zone Lymphoma

Autoimmune Hemolytic Anemia as a Risk Factor of Poor Outcome in Patients with Splenic Marginal Zone Lymphoma

2009 ◽  
Vol 15 (4) ◽  
pp. 597-603 ◽  
Author(s):  
Aniko Fodor ◽  
Miklos Zsolt Molnar ◽  
Laszlo Krenacs ◽  
Eniko Bagdi ◽  
Judit Csomor ◽  
...  
Keyword(s):  
Risk Factor ◽  
Hemolytic Anemia ◽  
Autoimmune Hemolytic Anemia ◽  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Splenic Marginal Zone Lymphoma ◽  
Poor Outcome

Repertoire of IgVH Genes in Splenic Marginal Zone Lymphoma Complicated with Autoimmune Hemolytic Anemia

2017 ◽  
Vol 17 ◽  
pp. S391
Author(s):  
Hunan Julhakyan ◽  
Bella Biderman ◽  
Nina Tsvetaeva ◽  
Lyubov Al-Radi ◽  
Tatyana Moiseeva ◽  
...  
Keyword(s):  
Hemolytic Anemia ◽  
Autoimmune Hemolytic Anemia ◽  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Splenic Marginal Zone Lymphoma

No evidence of splenic disease in patients with splenic marginal zone lymphoma undergoing splenectomy for autoimmune hemolytic anemia after monotherapy with rituximab

2016 ◽  
Vol 57 (11) ◽  
pp. 2705-2708 ◽  
Author(s):  
Christina Kalpadakis ◽  
Gerassimos A. Pangalis ◽  
Sotirios Sachanas ◽  
Demetra Rontogianni ◽  
Penelope Korkolopoulou ◽  
...  
Keyword(s):  
Hemolytic Anemia ◽  
Autoimmune Hemolytic Anemia ◽  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Splenic Marginal Zone Lymphoma ◽  
Splenic Disease

scholarly journals Successful Treatment of Leukemic Mature B-Cell Lymphoid Neoplasm with Similar Features to Splenic Marginal Zone Lymphoma Possessing Aberrant Myeloid Markers

2015 ◽  
Vol 2015 ◽  
pp. 1-4
Author(s):  
Shinsaku Imashuku ◽  
Naoko Kudo ◽  
Kagekatsu Kubo ◽  
Katsuyasu Saigo
Keyword(s):  
B Cell ◽  
Marginal Zone ◽  
Lymphoproliferative Disease ◽  
Marginal Zone Lymphoma ◽  
Splenic Marginal Zone Lymphoma ◽  
Aberrant Expression ◽  
Cell Counts ◽  
Old Japanese ◽  
Characteristic Features ◽  
Leukemic Phase

In splenic marginal zone lymphoma (SMZL), there are cases that cannot accurately be classified as such because of overlapping morphologic and/or immunophenotypic features. We report here a 76-year-old Japanese female, who showed leukemic B-cell lymphoproliferative disease possessing characteristic features identified for SMZL. The patient was leukemic with white blood cell counts 49,400/µL (abnormal cells, 78.5%) and neoplastic cells were characterized by aberrant expression of myeloid markers with CD19+CD13+(64.2%) and CD20+CD11c+(25.1%). Considering her history of previous chemotherapy and systemic leukemic phase of the disease, we treated the patient without performing splenectomy, with successful use of a combination of rituximab/bendamustine hydrochloride and of rituximab/cladribine. The patient has been in a complete remission longer than 44 months, with no detectable M-protein.

Activity of Rituximab Monotherapy in Refractory Splenic Marginal Zone Lymphoma Complicated with Autoimmune Hemolytic Anemia

2006 ◽  
Vol 6 (6) ◽  
pp. 496-499 ◽  
Author(s):  
Alberto Fabbri ◽  
Alessandro Gozzetti ◽  
Stefano Lazzi ◽  
Mariapia Lenoci ◽  
Alessandro D'Amuri ◽  
...  
Keyword(s):  
Hemolytic Anemia ◽  
Autoimmune Hemolytic Anemia ◽  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Splenic Marginal Zone Lymphoma
Sign in / Sign up

Export Citation Format

Share Document